Showing results (81-90 of 203) with videos related to
Sort By:
Pageof 21
Arzneimittel-Forschung|September 1, 1975
The pharmacodynamics of orally taken verapamil and verapamil retard as judged by their negative dromotropic effectsM Schlepper, J Thormann, F SchwarzCardiology|January 1, 1982
Coronary hemodynamics in simulated paroxysms of ventricular tachycardia: role of myocardial impairment and of extravascular resistanceJ Thormann, M Schlepper, H NeussZeitschrift Fur Kardiologie|May 1, 1981
[Hemodynamics and metabolic-energetic expenses of the influence of AR-L115 in patients with coronary artery disease (author's transl)]J Thormann, W Kramer, M SchlepperZeitschrift Fur Kardiologie|October 1, 1980
[Echo parameters of chronic aortic regurgitation (author's transl)]W Kramer, M Gottwik, M SchlepperCatheterization and Cardiovascular Diagnosis|January 1, 1983
Diurnal changes and reproducibility of corrected sinus node recovery timeJ Thormann, M Schlepper, W KramerInternational Journal of Clinical Pharmacology and Therapeutics|July 1, 1994
Steady-state plasma concentrations of propafenone--chirality and metabolismM Volz, V Mitrovic, M SchlepperCirculation|January 1, 1975
Analysis of re-entry mechanisms in the three patients with concealed Wolff-Parkinson-White syndromeH Neuss, M Schlepper, J ThormannJournal of Chromatography|October 22, 1993
Rapid and sensitive assay of dobutamine in plasma by high-performance liquid chromatography and electrochemical detectionH Husseini, V Mitrovic, M SchlepperClinical and Experimental Pharmacology & Physiology|May 1, 1982
AR-L 115 in coronary artery disease: positive inotropic effects and increase of left-ventricular pump function without inducing anginaJ Thormann, M Schlepper, W KramerAmerican Heart Journal|December 1, 1982
Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery diseaseJ Thormann, W Kramer, M SchlepperPageof 21